United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 373.785 USD 3.43% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

United Therapeutics Corp
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

United Therapeutics Corp
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
United Therapeutics Corp
NASDAQ:UTHR
Cash Equivalents
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
18%
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$13.1B
CAGR 3-Years
15%
CAGR 5-Years
20%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$2.8B
CAGR 3-Years
-17%
CAGR 5-Years
-24%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9.3B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
8%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$4.6B
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$1.9B
CAGR 3-Years
-2%
CAGR 5-Years
13%
CAGR 10-Years
12%

See Also

What is United Therapeutics Corp's Cash Equivalents?
Cash Equivalents
1.4B USD

Based on the financial report for Jun 30, 2024, United Therapeutics Corp's Cash Equivalents amounts to 1.4B USD.

What is United Therapeutics Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
18%

Over the last year, the Cash Equivalents growth was 27%. The average annual Cash Equivalents growth rates for United Therapeutics Corp have been 13% over the past three years , 9% over the past five years , and 18% over the past ten years .

Back to Top